Test Bank
Abrams' Clinical Drug Therapy:
Rationales for Nursing Practice
3
13th Edition
By Geralyn Frandsen & Sandra Pennington
Complete Chapter Guide 1-61 With Rationales| A+ PASS
13|3P3a3g3e
, Table3of3Content3SEC
TION313The3Conceptual3Framework3of3Pharmacology3Chapter313
The3Foundation3of3Pharmacology:3Quality3and3Safety3Chapter323Bas
ic3Concepts3and3Processes
Chapter333Medication3Administration3and3the3Nursing3Process3of3Drug3Therapy
SECTION323Drug3Therapy3Throughout3the3Lifespan
Chapter343Pharmacology3and3the3Care3of3Infants3and3Pediatric3Patients3Medication3Administration3in3Pe
diatrics
Chapter353Pharmacology3and3the3Care3of3Adults3and3Geriatric3Patients3
Chapter363Pharmacology3and3the3Care3of3Pregnant3or3Lactating3Woman3
Chapter373Pharmacology3and3Women‘s3Health
Chapter383Pharmacology3and3Men‘s3Health
SECTION333Drugs3Affecting3the3Hematopoietic3and3Immune3Systems
Chapter393Drug3Therapy3for3Coagulation3Disorders3C
hapter3103Drug3Therapy3for3Dyslipidemia
Chapter3113Drug3Therapy3for3Hematopoietic3Disorder
s3Chapter3123Drug3Therapy:3Immunizations
Chapter3133Drug3Therapy3to3Decrease3Immunity3Cha
pter3143Drug3Therapy3for3the3Treatment3of3Cancer
SECTION343Drugs3Affecting3Inflammation3and3Infection
Chapter3153Inflammation,3Infection,3and3the3Use3of3Antimicrobial3Agent
s3Chapter3163Drug3Therapy3to3Decrease3Pain,3Fever,3and3Inflammation3
Chapter3173Drug3Therapy3With3Corticosteroids
Chapter3183Drug3Therapy3With3Beta-
Lactam3Antibacterial3Agents3Chapter3193Drug3Therapy3With3Aminoglyc
osides3and3Fluoroquinolones
Chapter3203Drug3Therapy3With3Tetracyclines,3Sulfonamides,3and3Urinary3Antiseptics3Ch
apter3213Drug3Therapy3With3Macrolides3and3Miscellaneous3Anti-
infective3Agents3Chapter3223Drug3Therapy3for3Tuberculosis3and3Mycobacterium3avium3C
omplex3Disease3Chapter3233Drug3Therapy3for3Viral3Infections
23|3P3a3g3e
,Chapter3243Drug3Therapy3for3Fungal3Infections3Chap
ter3253Drug3Therapy3for3Parasitic3Infections
SECTION353Drugs3Affecting3the3Cardiovascular3System
Chapter3263Drug3Therapy3for3Hypertension3Cha
pter3273Drug3Therapy3for3Dysrhythmias
Chapter3283Drug3Therapy3for3Coronary3Heart3Diseas
e3Chapter3293Drug3Therapy3for3Shock3and3Hypotens
ion3Chapter3303Drug3Therapy3for3Heart3Failure
SECTION363Drugs3Affecting3the3Respiratory3System
Chapter3313Drug3Therapy3for3Nasal3Congestion3and3Cough
Chapter3323Drug3Therapy3to3Decrease3Histamine3Effects3and3Allergic3Response3
Chapter3333Drug3Therapy3for3Asthma3and3Bronchoconstriction
SECTION373Drugs3Affecting3the3Renal3and3Digestive3Systems
Chapter3343Drug3Therapy3for3Fluid3Volume3Excess
Chapter3353Nutritional3Support3Products,3Vitamins,3and3Mineral3Supplements3Ch
apter3363Drug3Therapy3for3Weight3Management
Chapter3373Drug3Therapy3for3Peptic3Ulcer3Disease3and3Hyperacidity
3Chapter3383Drug3Therapy3for3Nausea3and3Vomiting
Chapter3393Drug3Therapy3for3Constipation3and3Elimination3Problems
3Chapter3403Drug3Therapy3for3Diarrhea
SECTION383Drugs3Affecting3the3Endocrine3System3C
hapter3413Drug3Therapy3for3Diabetes3Mellitus
Chapter3423Drug3Therapy3for3Hyperthyroidism3and3Hypothyroidism3Cha
pter3433Drug3Therapy3for3Pituitary3and3Hypothalamic3Dysfunction3Chapt
er3443Drug3Therapy3to3Regulate3Calcium3and3Bone3Metabolism3Chapter3
453Drug3Therapy3for3Addison‘s3Disease3and3Cushing‘s3Disease3Section3
93Drugs3Affecting3the3Autonomic3and3Central3Nervous3System
Chapter3463Physiology3of3the3Autonomic3and3Central3Nervous3Systems3and3Indications3for3the3Use3of3
Drug3Therapy
33|3P3a3g3e
, Chapter3473Drug3Therapy3for3Myasthenia3Gravis,3Alzheimer‘s3Disease,3and3Urinary3Retention
Chapter3483Drug3Therapy3for3Parkinson‘s3Disease,3Urinary3Spasticity,3and3Disorders3Requiring
Anticholinergic3Drug3Therapy
Chapter3493Drug3Therapy3With3Opioids
Chapter3503Drug3Therapy3With3Local3Anesthetics3
Chapter3513Drug3Therapy3With3General3Anesthetic
s
Chapter3523Drug3Therapy3for3Migraines3and3Other3Headache
s3Chapter3533Drug3Therapy3for3Seizure3Disorders3and3Spastic
ity3Chapter3543Drug3Therapy3for3Anxiety3and3Insomnia
Chapter3553Drug3Therapy3for3Depression3and3Mood3Stabilization3Ch
apter3563Drug3Therapy3for3Psychotic3Disorders
Chapter3573Drug3Therapy3for3Attention3Deficit3Hyperactivity3Disorder3and3Narcolepsy3C
hapter3583Drug3Therapy3for3Substance3Abuse3Disorders
Section3103Drugs3Affecting3the3Eye,3Ear,3and3Skin3
Chapter3593Drug3Therapy3for3Disorders3of3the3Eye3C
hapter3603Drug3Therapy3for3Disorders3of3the3Ear3Cha
pter3613Drug3Therapy3for3Disorders3of3the3Skin
Chapter313:3The3Foundation3of3Pharmacology:3Quality3and3Safety3:
1. A3woman3diagnosed3with3obsessive–
compulsive3disorder3has3been3prescribed3oral3paroxetine3hydrochloride.3What3is3the3expected3
effect3for3this3prescription?
A. Curative3effect3on3symptoms
B. Systemic3effect3on3symptoms
C. Local3effect3on3symptoms
D. Parenteral3effect3on3symptom
s3ANS:3B
Rationale:3Drugs3that3produce3systemic3effects3are3taken3into3the3body,3circulated3through3the3bloodstr
eam3to3their3sites3of3action3in3various3body3tissues,3and3eventually3eliminated3from3the3body.3Curative3
43|3P3a3g3e
Abrams' Clinical Drug Therapy:
Rationales for Nursing Practice
3
13th Edition
By Geralyn Frandsen & Sandra Pennington
Complete Chapter Guide 1-61 With Rationales| A+ PASS
13|3P3a3g3e
, Table3of3Content3SEC
TION313The3Conceptual3Framework3of3Pharmacology3Chapter313
The3Foundation3of3Pharmacology:3Quality3and3Safety3Chapter323Bas
ic3Concepts3and3Processes
Chapter333Medication3Administration3and3the3Nursing3Process3of3Drug3Therapy
SECTION323Drug3Therapy3Throughout3the3Lifespan
Chapter343Pharmacology3and3the3Care3of3Infants3and3Pediatric3Patients3Medication3Administration3in3Pe
diatrics
Chapter353Pharmacology3and3the3Care3of3Adults3and3Geriatric3Patients3
Chapter363Pharmacology3and3the3Care3of3Pregnant3or3Lactating3Woman3
Chapter373Pharmacology3and3Women‘s3Health
Chapter383Pharmacology3and3Men‘s3Health
SECTION333Drugs3Affecting3the3Hematopoietic3and3Immune3Systems
Chapter393Drug3Therapy3for3Coagulation3Disorders3C
hapter3103Drug3Therapy3for3Dyslipidemia
Chapter3113Drug3Therapy3for3Hematopoietic3Disorder
s3Chapter3123Drug3Therapy:3Immunizations
Chapter3133Drug3Therapy3to3Decrease3Immunity3Cha
pter3143Drug3Therapy3for3the3Treatment3of3Cancer
SECTION343Drugs3Affecting3Inflammation3and3Infection
Chapter3153Inflammation,3Infection,3and3the3Use3of3Antimicrobial3Agent
s3Chapter3163Drug3Therapy3to3Decrease3Pain,3Fever,3and3Inflammation3
Chapter3173Drug3Therapy3With3Corticosteroids
Chapter3183Drug3Therapy3With3Beta-
Lactam3Antibacterial3Agents3Chapter3193Drug3Therapy3With3Aminoglyc
osides3and3Fluoroquinolones
Chapter3203Drug3Therapy3With3Tetracyclines,3Sulfonamides,3and3Urinary3Antiseptics3Ch
apter3213Drug3Therapy3With3Macrolides3and3Miscellaneous3Anti-
infective3Agents3Chapter3223Drug3Therapy3for3Tuberculosis3and3Mycobacterium3avium3C
omplex3Disease3Chapter3233Drug3Therapy3for3Viral3Infections
23|3P3a3g3e
,Chapter3243Drug3Therapy3for3Fungal3Infections3Chap
ter3253Drug3Therapy3for3Parasitic3Infections
SECTION353Drugs3Affecting3the3Cardiovascular3System
Chapter3263Drug3Therapy3for3Hypertension3Cha
pter3273Drug3Therapy3for3Dysrhythmias
Chapter3283Drug3Therapy3for3Coronary3Heart3Diseas
e3Chapter3293Drug3Therapy3for3Shock3and3Hypotens
ion3Chapter3303Drug3Therapy3for3Heart3Failure
SECTION363Drugs3Affecting3the3Respiratory3System
Chapter3313Drug3Therapy3for3Nasal3Congestion3and3Cough
Chapter3323Drug3Therapy3to3Decrease3Histamine3Effects3and3Allergic3Response3
Chapter3333Drug3Therapy3for3Asthma3and3Bronchoconstriction
SECTION373Drugs3Affecting3the3Renal3and3Digestive3Systems
Chapter3343Drug3Therapy3for3Fluid3Volume3Excess
Chapter3353Nutritional3Support3Products,3Vitamins,3and3Mineral3Supplements3Ch
apter3363Drug3Therapy3for3Weight3Management
Chapter3373Drug3Therapy3for3Peptic3Ulcer3Disease3and3Hyperacidity
3Chapter3383Drug3Therapy3for3Nausea3and3Vomiting
Chapter3393Drug3Therapy3for3Constipation3and3Elimination3Problems
3Chapter3403Drug3Therapy3for3Diarrhea
SECTION383Drugs3Affecting3the3Endocrine3System3C
hapter3413Drug3Therapy3for3Diabetes3Mellitus
Chapter3423Drug3Therapy3for3Hyperthyroidism3and3Hypothyroidism3Cha
pter3433Drug3Therapy3for3Pituitary3and3Hypothalamic3Dysfunction3Chapt
er3443Drug3Therapy3to3Regulate3Calcium3and3Bone3Metabolism3Chapter3
453Drug3Therapy3for3Addison‘s3Disease3and3Cushing‘s3Disease3Section3
93Drugs3Affecting3the3Autonomic3and3Central3Nervous3System
Chapter3463Physiology3of3the3Autonomic3and3Central3Nervous3Systems3and3Indications3for3the3Use3of3
Drug3Therapy
33|3P3a3g3e
, Chapter3473Drug3Therapy3for3Myasthenia3Gravis,3Alzheimer‘s3Disease,3and3Urinary3Retention
Chapter3483Drug3Therapy3for3Parkinson‘s3Disease,3Urinary3Spasticity,3and3Disorders3Requiring
Anticholinergic3Drug3Therapy
Chapter3493Drug3Therapy3With3Opioids
Chapter3503Drug3Therapy3With3Local3Anesthetics3
Chapter3513Drug3Therapy3With3General3Anesthetic
s
Chapter3523Drug3Therapy3for3Migraines3and3Other3Headache
s3Chapter3533Drug3Therapy3for3Seizure3Disorders3and3Spastic
ity3Chapter3543Drug3Therapy3for3Anxiety3and3Insomnia
Chapter3553Drug3Therapy3for3Depression3and3Mood3Stabilization3Ch
apter3563Drug3Therapy3for3Psychotic3Disorders
Chapter3573Drug3Therapy3for3Attention3Deficit3Hyperactivity3Disorder3and3Narcolepsy3C
hapter3583Drug3Therapy3for3Substance3Abuse3Disorders
Section3103Drugs3Affecting3the3Eye,3Ear,3and3Skin3
Chapter3593Drug3Therapy3for3Disorders3of3the3Eye3C
hapter3603Drug3Therapy3for3Disorders3of3the3Ear3Cha
pter3613Drug3Therapy3for3Disorders3of3the3Skin
Chapter313:3The3Foundation3of3Pharmacology:3Quality3and3Safety3:
1. A3woman3diagnosed3with3obsessive–
compulsive3disorder3has3been3prescribed3oral3paroxetine3hydrochloride.3What3is3the3expected3
effect3for3this3prescription?
A. Curative3effect3on3symptoms
B. Systemic3effect3on3symptoms
C. Local3effect3on3symptoms
D. Parenteral3effect3on3symptom
s3ANS:3B
Rationale:3Drugs3that3produce3systemic3effects3are3taken3into3the3body,3circulated3through3the3bloodstr
eam3to3their3sites3of3action3in3various3body3tissues,3and3eventually3eliminated3from3the3body.3Curative3
43|3P3a3g3e
